
Pharma Pulse 11/26/24: RFID Technological Obstacles, Self-Care for the Flu & more
The latest news for pharma industry insiders.
In the second part of this roundtable discussion, key opinion leaders discuss the potential technological challenges surrounding RFID, and the likelihood of not only utilizing this tech at the item level but for product security purposes as well.
The panel consisted of Matt Campasano, Managing Director, Criterion Consulting; Sean O’Hearen; Founder & Principal Consultant, 1st Line Partners; Tim Marsh, Founder & Head of Strategy, MDB; and Bahar Aliakbarian, PhD, Associate Professor, Sr. Director of R&D, Axia Institute (at Michigan State University).
CR is a 7-month-old boy who is brought to the pharmacy by his mother. She informs the pharmacist that she received her annual flu vaccine a week ago and is now considering whether CR should also receive the vaccine. She has concerns because she read online about potential links between vaccines and autism.
The world’s largest philanthropic fund that ultimately controls Novo Nordisk A/S will ramp up its investments outside of Denmark after cashing in on the weight-loss drug boom.
VIVIO announced PrecisionCare One™, an extension of its proven open-market specialty drug management platform to include all drugs. This builds on VIVIO’s prior success in managing complex specialty medications across pharmacy and medical benefits, where its clinical-first approach has delivered cost-effective outcomes in oncology, rheumatology, multiple sclerosis, HIV, and other specialized therapeutic areas.
Tremendously thankful to the panel of healthcare providers, patients and caregivers for recognizing Scientific Global at Pharmaceutical Executive's Apex Awards. Three nominations and three wins! Congratulations to our team and our incredible partners at Alora Pharmaceuticals, LLC and Cerapedics Inc. #TheMedEdge #ApexAwards
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

